Categories: EHRHealthcareNews

NextGen Healthcare to Report Fiscal 2024 First Quarter Results

REMOTE-FIRST COMPANY/NEW YORK–(BUSINESS WIRE)–$NXGN #NextGenHealthcare–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative cloud-based healthcare technology solutions, today announced that it will release its fiscal 2024 first quarter results on Monday, July 24, 2023, after market close. In conjunction, the company will host a conference call to discuss the results and provide an update on its operations and strategy at 5 p.m. EST the same day.


Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 800-343-4136 or 203-518-9843 for international callers and referencing participant code NXGNQ124 approximately 15 minutes prior to the call.

A recording of the event will be available at investor.nextgen.com. It will be archived for 90 days.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of innovative healthcare technology solutions. We are reimagining ambulatory healthcare with award-winning solutions that enable high-performing practices to create healthier communities. We partner with medical, behavioral and oral health providers in their journey toward whole person health and value-based care. Our highly integrated, intelligent and interoperable solutions go beyond EHR and Practice Management to increase clinical quality and productivity, enrich the patient experience and drive superior financial performance. We are on a quest to achieve better healthcare outcomes for all. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Contacts

Media Contact
Tami Andrade

(949) 237-6083

tandrade@nextgen.com

Investor Relations Contact
James Hammerschmidt

949-237-6112

JHammerschmidt@nextgen.com

Staff

Recent Posts

TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida

New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B…

29 minutes ago

NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

29 minutes ago

TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in…

2 hours ago

Building a Healthier Future Together: Strengthening Cancer Care Across Africa Through Partnership

NORTHAMPTON, MA / ACCESS Newswire / December 17, 2025 / Originally published on Bristol Myers…

2 hours ago

Restart Life Announces Food Technology and Research Studies

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

4 hours ago